openPR Logo
Press release

Lawsuit filed for Investors in shares of Fluidigm Corporation (NASDAQ: FLDM)

10-02-2020 09:23 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Fluidigm Corporation (NASDAQ: FLDM) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Fluidigm Corporation (NASDAQ: FLDM) shares over alleged securities laws violations.

The Shareholders Foundation announced that an investor, who purchased shares of Fluidigm Corporation (NASDAQ: FLDM), filed a lawsuit over alleged violations of Federal Securities Laws by Fluidigm Corporation

Investors who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) have certain options and for certain investors are short and strict deadlines running. Deadline: November 20, 2020. NASDAQ: FLDM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 1, 2019, Fluidigm Corporation reported second quarter 2019 revenue of $28.2 million, well below analysts’ expectations of $32 million, citing weakness in its microfluidics segment.

Then, on November 5, 2019, after the market closed, Fluidigm Corporation reported that third quarter 2019 revenue declined 8.5% year-over-year primarily due to mass cytometry instrument sales.

Shares of Fluidigm Corporation (NASDAQ: FLDM) declined from $14.50 per share in March 2019 to as low as $2.31 per share on November 8, 2019.

The plaintiff claims that between February 7, 2019 and November 5, 2019, the Defendants failed to disclose to investors that Fluidigm was experiencing longer sales cycles that, as a result, Fluidigm’s revenue was reasonably likely to decline, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) have certain options and should contact the Shareholders Foundation.

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Fluidigm Corporation (NASDAQ: FLDM) here

News-ID: 2148744 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Fluidigm

Real Time PCR Kit Market Still Going Strong | Fluidigm, Takara Bio, Danaher, Flu …
Real-time PCR helps in simultaneous amplification and detection of nucleic acids by the help of polymerase chain reaction (PCR). qPCR is a versatile technique which supports various research applications. Real-time PCR delivers sensitivity, specificity, and a wide dynamic range for detecting target nucleic acids. It is becoming a powerful technology for research applications which is able to cover the spectrum of biology from basic research to translational medicine to applied
Global Genetic Analyzers Market 2020-2026 Danaher, Agilent Technologies, Fluidig …
The Global Genetic Analyzers Market research 2020-2026 is a specialized and in-depth study of industry with a focus on the global market trend. The Genetic Analyzers report aims to provide an outline of world market with elaborated market segmentation by product, end user, and regions. The global Genetic Analyzers market is predicted to witness high growth throughout the forecast period. The report provides key statistics on the market standing of
Biochips Market Boosting the growth Worldwide| Leading Key Players: Abbott, BioC …
Latest research study from HTF MI with title Global Biochips by Manufacturers, Regions, Type and Application, Forecast to 2023. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type, application/end-users. The research study provides estimates for Global Biochips Forecast till 2023. If you
Global SNP Genotyping and Analysis Market 2017 - Sequenom, Illumina, Roche, Affy …
Apex Market Reports, recently published a detailed market research study focused on the "SNP Genotyping and Analysis Market" across the global, regional and country level. The report provides 360° analysis of "SNP Genotyping and Analysis Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global SNP Genotyping and Analysis industry, and estimates the
Biochip Market in-depth with inputs from industry experts- Perkinelmer, Fluidigm …
Global Biochip Sales Market Report 2017 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. This study recognizes that in this quick-evolving, competitive environment, up-to-date industry information is essential to monitor performance & make critical decisions for growth and profitability. It provides information on trends and developments, focuses on markets and materials, capacities, technologies, and on
Biochip Market 2017 Global Key Players- Abbott Laboratories, Agilent Technologie …
The Global Biochip Market Research Report 2017 to 2022 renders deep perception of the key regional market status of the Biochip Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan. To Get Sample Copy of Report visit @ https://www.qyresearchgroups.com/request-sample/538288 The report on “Global Biochip Market” is a